In my view,PR information from this company has been painfully inadequate. The last news we received was back at the end of January regarding the resolution of the case with the crooked creditors. it was, indeed, good news that this was favorably resolved. Surely, at this point, with February basically now gone, SVFC strongly needs to consider posting information/data regarding the status of their gene therary treatment progress. This is what we and the market are waiting for. It's encouranging that the share price has remained stable and even improved recently with total quiet for the company executives. However, I personnaly believe it's time to provide an honest and informative bit of PR to let their investors know where this is all going. JMHO. GLTAL!